Prognostic risk-stratified score for predicting mortality in hospitalized patients with thrombotic thrombocytopenic purpura: Nationally representative data from 2007 to 2012

Transfusion

Volumn 56, Issue 6, 2016, Pages 1451-1458

  Goel, Ruchika ^a   King, Karen E ^a   Takemoto, Clifford M ^a   Ness, Paul M ^a   Tobian, Aaron A R ^a  

^a JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ADULT; ARTERY THROMBOSIS; ARTICLE; BLEEDING; BRAIN HEMORRHAGE; BRAIN ISCHEMIA; CHRONIC KIDNEY FAILURE; ERYTHROCYTE TRANSFUSION; FEMALE; HEART INFARCTION; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HOSPITAL MORTALITY; HOSPITAL PATIENT; HUMAN; KIDNEY FAILURE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MORTALITY RATE; SCORING SYSTEM; SENSITIVITY ANALYSIS; SENSITIVITY AND SPECIFICITY; THROMBOCYTE TRANSFUSION; THROMBOTIC THROMBOCYTOPENIC PURPURA; ADOLESCENT; AGED; CHILD; HOSPITALIZATION; INFANT; MIDDLE AGED; NEWBORN; PLASMA EXCHANGE; PREDICTIVE VALUE; PRESCHOOL CHILD; PROCEDURES; PROGNOSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHILD; CHILD, PRESCHOOL; FEMALE; HOSPITAL MORTALITY; HOSPITALIZATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; MIDDLE AGED; PLASMA EXCHANGE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; PURPURA, THROMBOTIC THROMBOCYTOPENIC; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; YOUNG ADULT;

EID: 84963538101     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/trf.13586     Document Type: Article

References (37)

1. George JN., Clinical practice. Thrombotic thrombocytopenic purpura. N Engl J Med 2006; 354: 1927-35.
2. George JN., How I treat patients with thrombotic thrombocytopenic purpura: 2010. Blood 2010; 116: 4060-9.
3. Sadler JE, Moake JL, Miyata T, et al., Recent advances in thrombotic thrombocytopenic purpura. Hematology Am Soc Hematol Educ Program 2004; 407-23.
4. Adamski J., Thrombotic microangiopathy and indications for therapeutic plasma exchange. Hematology Am Soc Hematol Educ Program 2014; 2014: 444-9.
5. Raval JS, Mazepa MA, Brecher ME, et al., How we approach an acquired thrombotic thrombocytopenic purpura patient. Transfusion 2014; 54: 2375-82.
6. Sarode R, Bandarenko N, Brecher ME, et al., Thrombotic thrombocytopenic purpura: 2012 American Society for Apheresis (ASFA) consensus conference on classification, diagnosis, management, and future research. J Clin Apher 2014; 29: 148-67.
7. Bandarenko N, Brecher ME., United States Thrombotic Thrombocytopenic Purpura Apheresis Study Group (US TTP ASG): multicenter survey and retrospective analysis of current efficacy of therapeutic plasma exchange. J Clin Apher 1998; 13: 133-41.
8. Cox EC., Thrombotic thrombocytopenic purpura: report of three additional cases and a short review of the literature. J S C Med Assoc 1966; 62: 465-70.
9. Rock GA, Shumak KH, Buskard NA, et al., Comparison of plasma exchange with plasma infusion in the treatment of thrombotic thrombocytopenic purpura. Canadian Apheresis Study Group. N Engl J Med 1991; 325: 393-7.
10. Bell WR, Braine HG, Ness PM, et al., Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients. N Engl J Med 1991; 325: 398-403.
11. Török TJ, Holman RC, Chorba TL., Increasing mortality from thrombotic thrombocytopenic purpura in the United States-analysis of national mortality data, 1968-1991. Am J Hematol 1995; 50: 84-90.
12. Kremer Hovinga JA, Vesely SK, Terrell DR, et al., Survival and relapse in patients with thrombotic thrombocytopenic purpura. Blood 2010; 115: 1500-11, quiz 1662.
13. Benhamou Y, Assie C, Boelle PY, et al., Development and validation of a predictive model for death in acquired severe ADAMTS13 deficiency-associated idiopathic thrombotic thrombocytopenic purpura: the French TMA Reference Center experience. Haematologica 2012; 97: 1181-6.
14. Deford CC, Reese JA, Schwartz LH, et al., Multiple major morbidities and increased mortality during long-term follow-up after recovery from thrombotic thrombocytopenic purpura. Blood 2013; 122: 2023-9; quiz 2142.
15. Goel R, Ness PM, Takemoto CM, et al., Platelet transfusions in platelet consumptive disorders are associated with arterial thrombosis and in-hospital mortality. Blood 2015; 125: 1470-6.
16. Fast facts on US hospitals [Internet]. Chicago (IL): American Hospital Association; 2014 [cited 2016 Mar 21]. Available from: http://www.aha.org/research/rc/stat-studies/fast-facts.shtml.
17. Nationwide data use agreement [Internet]. Silver Spring (MD): Healthcare Cost and Utilization Project (HCUP); 2014 [cited 2016 Mar 21]. Available from: http://www.hcup-us.ahrq.gov/team/NationwideDUA.jsp.
18. Localio AR, Berlin JA, Ten Have TR, et al., Adjustments for center in multicenter studies: an overview. Ann Intern Med 2001; 135: 112-23.
19. Hicks CW, Hashmi ZG, Velopulos C, et al., Association between race and age in survival after trauma. JAMA Surg 2014; 149: 642-7.
20. 3M™ APR DRG Software [Internet]. Salt Lake City (UT): 3M Health Information Systems; 2014 [cited 2016 Mar 21]. Available from: http://solutions.3m.com/wps/portal/3M/en-US/Health-Information-Systems/HIS/Products-and-Services/Products-List-A-Z/APR-DRG-Software/.
21. Kiss JE., Thrombotic thrombocytopenic purpura: recognition and management. Int J Hematol 2010; 91: 36-45.
22. Scully M, Hunt BJ, Benjamin S, et al., Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 2012; 158: 323-35.
23. von Baeyer H., Plasmapheresis in thrombotic microangiopathy-associated syndromes: review of outcome data derived from clinical trials and open studies. Ther Apher 2002; 6: 320-8.
24. Brailey LL, Brecher ME, Bandarenko N., Apheresis and the thrombotic thrombocytopenic purpura syndrome: current advances in diagnosis, pathophysiology, and management. Ther Apher 1999; 3: 20-4.
25. George JN, Vesely SK, Terrell DR, et al., The Oklahoma Thrombotic Thrombocytopenic Purpura-haemolytic Uraemic Syndrome Registry. A model for clinical research, education and patient care. Hamostaseologie 2013; 33: 105-12.
26. Wyllie BF, Garg AX, Macnab J, et al., Thrombotic thrombocytopenic purpura/haemolytic uraemic syndrome: a new index predicting response to plasma exchange. Br J Haematol 2006; 132: 204-9.
27. Balasubramaniyam N, Kolte D, Palaniswamy C, et al., Predictors of in-hospital mortality and acute myocardial infarction in thrombotic thrombocytopenic purpura. Am J Med 2013; 126: 1016.e1-7.
28. Harkness DR, Byrnes JJ, Lian EC, et al., Hazard of platelet transfusion in thrombotic thrombocytopenic purpura. JAMA 1981; 246: 1931-3.
29. Ridolfi RL, Bell WR., Thrombotic thrombocytopenic purpura. Report of 25 cases and review of the literature. Medicine (Baltimore) 1981; 60: 413-28.
30. Wongwiangjunt S, Poungvarin N., Extensive bilateral ischemic stroke after platelet transfusion in thrombotic thrombocytopenic purpura (TTP): a case report. J Med Assoc Thai 2012; 95 Suppl 2: S256-60.
31. Tripathi SP, Deshpande AS, Khadse S, et al., Case of TTP with cerebral infarct secondary to platelet transfusion. Indian J Pediatr 2011; 78: 109-11.
32. Rojas JC, Banerjee C, Siddiqui F, et al., Pearls and oy-sters: acute ischemic stroke caused by atypical thrombotic thrombocytopenic purpura. Neurology 2013; 80: e235-8.
33. Downes KA, Yomtovian R, Tsai HM, et al., Relapsed thrombotic thrombocytopenic purpura presenting as an acute cerebrovascular accident. J Clin Apher 2004; 19: 86-9.
34. Brecher ME., How I approach a thrombotic thrombocytopenia purpura patient. Transfusion 2006; 46: 687-9.
35. Nichols L, Berg A, Rollins-Raval MA, et al., Cardiac injury is a common postmortem finding in thrombotic thrombocytopenic purpura patients: is empiric cardiac monitoring and protection needed? Ther Apher Dial 2015; 19: 87-92.
36. Hosler GA, Cusumano AM, Hutchins GM., Thrombotic thrombocytopenic purpura and hemolytic uremic syndrome are distinct pathologic entities. A review of 56 autopsy cases. Arch Pathol Lab Med 2003; 127: 834-9.
37. Veyradier A., Von Willebrand factor-a new target for ttp treatment? N Engl J Med 2016; 374: 583-5.